Table 3 Cytopenia (neutropenia, anemia, thrombocytopenia) grade ≥3 at day 30 and day 90.

From: Effect of early granulocyte-colony-stimulating factor administration in the prevention of febrile neutropenia and impact on toxicity and efficacy of anti-CD19 CAR-T in patients with relapsed/refractory B-cell lymphoma

 

All

early G-CSF

Control

p

 

n

%

n

%

n

%

 

Cytopenia at day 30

Neutropenia G ≥ 3

26

26%

9

39%

17

19.1%

0.17

Anemia G ≥ 3

6

6%

3

13%

3

3.4%

0.14

Thrombocytopenia G ≥ 3

24

24%

7

30%

17

19.1%

0.42

Cytopenia at day 90

Neutropenia G ≥ 3

11

13%

2

10%

9

10.1%

1

Anemia G ≥ 3

1

1%

1

5%

0

0%

0.24

Thrombocytopenia G ≥ 3

5

6%

3

16%

2

2.2%

0.09